Stay updated with breaking news from Scientific Boards. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Toronto, Ontario--(Newsfile Corp. - December 8, 2022) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the "Company" or "TELO") is pleased to announce the formation of a multiple myeloma advisory board
EQS-News: HepaRegeniX GmbH / Key word(s): Personnel HepaRegeniX appoints Dr. Andreas Busch as Senior Advisor 23.11.2022 / 09:00 CET/CEST The issuer is solely responsible for the content of this announcement. HepaRegeniX appoints Dr. Andreas Busch as Senior Advisor Tübingen (Germany), November 2...
- Dr. Busch transitions from Absci’s Board of Directors to Absci’s Executive Leadership team -With a proven track record advancing drugs from discovery to...
VANCOUVER, Wash., March 21, 2022 -- Absci Corporation , the drug and target discovery company harnessing deep learning AI and synthetic biology to expand the therapeutic potential of proteins,... | March 21, 2022
03.02.2022 iOmx Therapeutics Appoints Dr. Murray Yule as CMO to Lead Clinical Development | Chief Medical Officer | Dr. Murray Yule